Investigating how arginase 1 affects vision loss from retinal injuries
Role of Arginase 1 in Retinal Ischemia-Reperfusion Injury
This study is looking at how a specific enzyme called arginase 1 can help protect your eyes from damage caused by reduced blood flow, which is important for people with conditions like diabetic retinopathy and glaucoma, and it hopes to find new ways to improve treatments for these eye issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10953974 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms behind retinal ischemia, a condition that can lead to significant vision loss in diseases like diabetic retinopathy and glaucoma. The study aims to explore the role of the enzyme arginase 1 in protecting retinal cells from damage caused by reduced blood flow and subsequent restoration. By identifying how arginase 1 functions in the retina, the research seeks to uncover new therapeutic targets that could lead to better treatments for patients suffering from these eye conditions. The approach includes both laboratory experiments and analysis of cellular responses to ischemic injury.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from retinal ischemia-related conditions, such as diabetic retinopathy or glaucoma.
Not a fit: Patients with retinal conditions unrelated to ischemia or those who do not have any retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect vision in patients with retinal diseases.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways for neuroprotection in retinal diseases, indicating potential for success in this approach.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Fouda, Abdelrahman — Univ of Arkansas for Med Scis
- Study coordinator: Fouda, Abdelrahman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.